abstract |
The present invention provides a method of treating cancer progression, comprising determining the ratio of at least one other group of T cells comprising Treg-cell versus Th17 cells, Th1 cells and / or a group of Th2 cells in at least one sample Diagnosing and / or monitoring and / or predicting disease progression. |